CIBIC-Plus

2 papers1 finding

Human trial2

Interventions

1

NA-831

upin humans1

1 study

NA-831 improves CIBIC-Plus in humans (78%, p = 0.01).
“CIBIC-Plus showed 78 % patients improved (p = 0.01; ITT).”
Human trialmild and moderate AD24 weeks
Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity
ADA Scientific Sessions 2025 abstract13 Jun 2025

Latest

1 in 12 months

AAIC 2025 Abstract23 Dec

Neuro‐Metabolic Association in Alzheimer’s Disease and Obesity: Clinical Evaluation of NA‐831 and NA‐931

Randomised trial in 112 peopleAlzheimer's disease

ADA Scientific Sessions 2025 Abstract13 Jun

Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity

Randomised trial in peopleAlzheimer's disease